Yazar "Hoppensteadt, D" seçeneğine göre listele
Listeleniyor 1 - 9 / 9
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Blood levels of nitric oxide and its relevance to C-reactive protein, CD 40L, TF and TNF? in malignancy associated hypercoagulable state.: Pathologic implications.(Amer Soc Hematology, 2003) Fareed, D; Bick, R; Bacher, P; Iqbal, O; Tobu, M; Hoppensteadt, D; Demir, A[Abstract Not Available]Öğe Clinical and laboratory validation of the 2nd International Standard of low molecular weight heparin (IS 2003-01/608) in the anti-Xa. Anti-LIA heptest and prothrombinase induced clotting (PiCT) tests(Amer Soc Hematology, 2005) Hoppensteadt, D; Jeske, W; Fareed, D; Baltasar, F; Walenga, JM; Tobu, M; Demir, M[Abstract Not Available]Öğe Comparative study on the anticoagulant effects of low molecular weight heparins as measured by whole blood ACT, anti-Xa and a newly developed prothrombinase induced clotting time (PiCT) assay(Amer Soc Hematology, 2005) Hoppensteadt, D; Tobu, M; Wahi, R; Iqbal, O; Walenga, JM; Demir, M; Baltasar, F[Abstract Not Available]Öğe Frequency of anti-erythropoietin antibodies in patients with end stage renal disease treated with recombinant erythropoietin(Amer Soc Hematology, 2005) Hoppensteadt, D; Tobu, M; Fareed, D; Iqbal, O; Baltasar, F; Patel, C; Bansal, V[Abstract Not Available]Öğe Molecular heterogeneity in recombinant erythropoietin using surface enhanced laser induced desorption ionization (SELDI). clinical implications(Amer Soc Hematology, 2005) James, E; Maddineni, J; Fareed, J; Florian-Kujawski, M; Baltasar, F; Jeske, W; Hoppensteadt, D[Abstract Not Available]Öğe Potential role of ADAMTS13/FXI complexes in the pathogenesis of end stage rental disease(Amer Soc Hematology, 2005) Fareed, J; Hoppensteadt, D; Cunanan, J; Patel, C; Maddineni, J; Baltasar, F; Fareed, D[Abstract Not Available]Öğe Role of PAI-1 and TAFI in the mediation of fibrinolytic deficit in cancer patients.(Amer Soc Clinical Oncology, 2004) Florian-Kujawski, MR; Hoppensteadt, D; Iqbal, O; Demir, M; Tobu, M; Fareed, D; Fareed, J[Abstract Not Available]Öğe Upregulation of monocyte chemotactic protein-1 and CD40 ligand in cancer and its modulation by a LMWH enoxaparin: Observations from the Oncenox study.(Amer Soc Hematology, 2003) Fareed, J; Hoppensteadt, D; Iqbal, O; Tobu, M; Demir, A; Cort, S; Deitcher, SR[Abstract Not Available]Öğe Upregulation of monocyte chemotactic protein-1 and CD40 ligand in cancer patients and their modulation by subcutaneous enoxaparin-results from the ONCENOX study(Amer Soc Clinical Oncology, 2004) Iqbal, O; Tobu, M; Demir, MA; Hoppensteadt, D; Fareed, J; Cort, S; Deitcher, S[Abstract Not Available]
